TH
Insider
Theresa Heggie
DirectorTheresa Heggie (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BioCryst Pharmaceuticals, Inc. (BCRX). The largest single filing was $505K of BCRX (49,933 sh × $10.11, as filed), executed Mar 20.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$505K
shares × price, as filed
Last traded
Mar 20
Filed Mar 24
Median ADV $42.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
BCRX
BioCryst Pharmaceuticals, Inc.
BCRX · 0 buys · 2 sells
2 filings
Recent filings
BCRXSALE
BioCryst Pharmaceuticals, Inc.
View filing →
$505K49,933 sh × $10.11
Exec Mar 20
Filed Mar 24 · 5:30 PM ET BCRXSALE BioCryst Pharmaceuticals, Inc. View filing → $596K
70,000 sh × $8.51
Exec Aug 13 2025
Filed Aug 15 2025 · 5:30 PM ET